Aroui S, Aouey B, Chtourou Y, Meunier AC, Fetoui H, Kenani A (2016) Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma. Chem Biol Interact 244:195-203. doi:10.1016/j.cbi.2015.12.011
Bai XF, Ni XG, Zhao P, Liu SM, Wang HX, Guo B, Zhou LP, Liu F, Zhang JS, Wang K, Xie YQ, Shao YF, Zhao XH (2004) Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 10 (10):1466-1470. doi:10.3748/wjg.v10.i10.1466
Butz H, Németh K, Czenke D, Likó I, Czirják S, Zivkovic V, Baghy K, Korbonits M, Kovalszky I, Igaz P, Rácz K, Patócs A (2017) Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas. Pathol Oncol Res 23 (3):633-641. doi:10.1007/s12253-016-0163-5
Cheng SX, Tu Y, Zhang S (2013) FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression. PLoS One 8 (8):e72376. doi:10.1371/journal.pone.0072376
Fatehi M, Hunt C, Ma R, Toyota BD (2018) Persistent Disparities in Survival for Patients with Glioblastoma. World Neurosurg 120:e511-e516. doi:10.1016/j.wneu.2018.08.114
Fong Y, Shen KH, Chiang TA, Shih YW (2010) Acacetin inhibits TPA-induced MMP-2 and u-PA expressions of human lung cancer cells through inactivating JNK signaling pathway and reducing binding activities of NF-kappaB and AP-1. J Food Sci 75 (1):H30-38. doi:10.1111/j.1750-3841.2009.01438.x
Foo SL, Yap G, Cui J, Lim LHK (2019) Annexin-A1 - A Blessing or a Curse in Cancer? Trends Mol Med 25 (4):315-327. doi:10.1016/j.molmed.2019.02.004
Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, Rodrigo JP (2004) Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164 (1):73-79. doi:10.1016/s0002-9440(10)63098-2
Guidotti G, Brambilla L, Rossi D (2017) Cell-Penetrating Peptides: From Basic Research to Clinics. Trends Pharmacol Sci 38 (4):406-424. doi:10.1016/j.tips.2017.01.003
Ius T, Ciani Y, Ruaro ME, Isola M, Sorrentino M, Bulfoni M, Candotti V, Correcig C, Bourkoula E, Manini I, Pegolo E, Mangoni D, Marzinotto S, Radovic S, Toffoletto B, Caponnetto F, Zanello A, Mariuzzi L, Di Loreto C, Beltrami AP, Piazza S, Skrap M, Cesselli D (2018) An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells. Neuro Oncol 20 (6):776-787. doi:10.1093/neuonc/nox234
Jin H, Li D, Lin MH, Li L, Harrich D (2020) Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure. Viruses 12 (4). doi:10.3390/v12040415
Kan T, Meltzer SJ (2009) MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 9 (6):727-732. doi:10.1016/j.coph.2009.08.009
Kang H, Ko J, Jang SW (2012) The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells. Biochem Biophys Res Commun 423 (1):188-194. doi:10.1016/j.bbrc.2012.05.114
Kına I, Sultuybek GK, Soydas T, Yenmis G, Biceroglu H, Dirican A, Uzan M, Ulutin T (2019) Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma. Br J Neurosurg 33 (2):165-170. doi:10.1080/02688697.2018.1540764
King SE (2016) Matrix metalloproteinases: new directions toward inhibition in the fight against cancers. Future Med Chem 8 (3):297-309. doi:10.4155/fmc.15.184
Li X, Zheng L, Xia Q, Liu L, Mao M, Zhou H, Zhao Y, Shi J (2019) A novel cell-penetrating peptide protects against neuron apoptosis after cerebral ischemia by inhibiting the nuclear translocation of annexin A1. Cell Death Differ 26 (2):260-275. doi:10.1038/s41418-018-0116-5
Lim LH, Pervaiz S (2007) Annexin 1: the new face of an old molecule. FASEB J 21 (4):968-975. doi:10.1096/fj.06-7464rev
Liu YF, Zhang PF, Li MY, Li QQ, Chen ZC (2011) Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma. Clin Exp Metastasis 28 (5):413-425. doi:10.1007/s10585-011-9380-1
Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9 (3):153-166. doi:10.1038/nrc2602
Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, Itano T, Matsui H, Arima K, Shirai M, Maeba T, Sogawa K, Konishi R, Taniguchi K, Hatanaka Y, Hatase O, Nishioka M (1996) Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 24 (1):72-81. doi:10.1053/jhep.1996.v24.pm0008707286
Morioka N, Kodama K, Tomori M, Yoshikawa K, Saeki M, Nakamura Y, Zhang FF, Hisaoka-Nakashima K, Nakata Y (2019) Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice. Brain Behav Immun 78:116-130. doi:10.1016/j.bbi.2019.01.014
Pagliara V, Adornetto A, Mammì M, Masullo M, Sarnataro D, Pietropaolo C, Arcone R (2014) Protease Nexin-1 affects the migration and invasion of C6 glioma cells through the regulation of urokinase Plasminogen Activator and Matrix Metalloproteinase-9/2. Biochim Biophys Acta 1843 (11):2631-2644. doi:10.1016/j.bbamcr.2014.07.008
Patton KT, Chen HM, Joseph L, Yang XJ (2005) Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 47 (6):597-601. doi:10.1111/j.1365-2559.2005.02300.x
Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E, Parente L (2006) Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther 5 (6):643-647. doi:10.4161/cbt.5.6.2700
Shao G, Zhou H, Zhang Q, Jin Y, Fu C (2019) Advancements of Annexin A1 in inflammation and tumorigenesis. Onco Targets Ther 12:3245-3254. doi:10.2147/ott.s202271
Tadei MB, Mayorquim MV, de Souza CB, de Souza Costa S, Possebon L, Souza HR, Iyomasa-Pilon MM, Geromel MR, Girol AP (2018) Expression of the Annexin A1 and its correlation with matrix metalloproteinases and the receptor for formylated peptide-2 in diffuse astrocytic tumors. Ann Diagn Pathol 37:62-66. doi:10.1016/j.anndiagpath.2018.08.002
Tang Y, Lv P, Sun Z, Han L, Zhou W (2016) 14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway. PLoS One 11 (1):e0146070. doi:10.1371/journal.pone.0146070
Tu Y, Johnstone CN, Stewart AG (2017) Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes. Pharmacol Res 119:278-288. doi:10.1016/j.phrs.2017.02.011
Uhm JH, Porter AB (2017) Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era. Mayo Clin Proc 92 (6):995-1004. doi:10.1016/j.mayocp.2017.01.010
Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10 (3):310-315. doi:10.1038/nm996
Wang B, Zhao CH, Sun G, Zhang ZW, Qian BM, Zhu YF, Cai MY, Pandey S, Zhao D, Wang YW, Qiu W, Shi L (2019) IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65. Cancer Lett 447:93-104. doi:10.1016/j.canlet.2019.01.008
Wang LD, Yang YH, Liu Y, Song HT, Zhang LY, Li PL (2008) Decreased expression of annexin A1 during the progression of cervical neoplasia. J Int Med Res 36 (4):665-672. doi:10.1177/147323000803600407
Yu Z, Chen Y, Wang S, Li P, Zhou G, Yuan Y (2018) Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Cancer Lett 428:77-89. doi:10.1016/j.canlet.2018.04.033
Yuan R, Liu Q, Segeren HA, Yuniati L, Guardavaccaro D, Lebbink RJ, Westendorp B, de Bruin A (2019a) Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression. EMBO J 38 (20):e101430. doi:10.15252/embj.2018101430
Yuan Y, Zhou C, Yang Q, Ma S, Wang X, Guo X, Ding Y, Tang J, Zeng Y, Li D (2019b) HIV-1 Tat protein inhibits the hematopoietic support function of human bone marrow mesenchymal stem cells. Virus Res 273:197756. doi:10.1016/j.virusres.2019.197756